Clinical Trials Browser

revumenib × Gastrointestinal × 1 year × Clear all

NCT05731947 2026-01-29

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms